AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Learn more →

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

M.D. ANDERSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)

Phase 1

Active, not recruiting

Conditions: Spinal Neoplasms

Interventions: Radiation: Radiation Therapy

First Posted Date: 2007-07-30

Last Posted Date: 2025-01-09

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 150

Registration Number: NCT00508443

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Effects of Yoga in Breast Cancer Patients

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Behavioral: Yoga Group
Behavioral: Stretching Control Group
Behavioral: Waitlist Control Group
Other: Questionnaire

First Posted Date: 2007-07-30

Last Posted Date: 2022-09-01

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 191

Registration Number: NCT00508794

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy

Completed

Conditions: Endometrial Cancer
Cervical Cancer
Uterine Cancer

Interventions: Radiation: Intensity Modulated Radiotherapy (IMRT)
Procedure: CT Scan

First Posted Date: 2007-07-30

Last Posted Date: 2017-09-12

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 24

Registration Number: NCT00508703

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

RTA 402 in Advanced Solid Tumors or Lymphoid Malignancies

Phase 1

Completed

Conditions: Lymphoid Malignancies
Solid Tumors

Interventions: Drug: RTA 402

First Posted Date: 2007-07-30

Last Posted Date: 2012-07-30

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 21

Registration Number: NCT00508807

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Registry for Women Who Are At Risk Or May Have Lynch Syndrome

Completed

Conditions: Hereditary Nonpolyposis Colorectal Cancer
Lynch Syndrome

Interventions: Behavioral: Questionnaire

First Posted Date: 2007-07-30

Last Posted Date: 2024-08-09

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 323

Registration Number: NCT00508573

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Chemotherapy-Related Toxicities In Ovarian Cancer Patients

Completed

Conditions: Ovarian Cancer

Interventions: Behavioral: Interview
Behavioral: Questionnaire

First Posted Date: 2007-07-30

Last Posted Date: 2020-11-13

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 288

Registration Number: NCT00508378

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Screening for Gynecologic Cancers in Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Patients

Completed

Conditions: Colon Cancer

Interventions: Behavioral: Questionnaire

First Posted Date: 2007-07-30

Last Posted Date: 2016-03-11

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 93

Registration Number: NCT00508846

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Single Agent Alimta in Poor Performance Status in Non-small Cell Lung Cancer

Phase 2

Completed

Conditions: Lung Cancer

Interventions: Drug: Alimta

First Posted Date: 2007-07-27

Last Posted Date: 2017-02-13

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 64

Registration Number: NCT00508144

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Thermal Signature of Patients Undergoing Radiation Therapy

Withdrawn

Conditions: Lung Cancer

Interventions: Procedure: Thermal Imaging

First Posted Date: 2007-07-27

Last Posted Date: 2016-04-08

Lead Sponsor: M.D. Anderson Cancer Center

Registration Number: NCT00508313

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Pemetrexed (Alimta) in Patients With Head and Neck Squamous Cell Cancer

Phase 1

Completed

Conditions: Head and Neck Cancer

Interventions: Drug: Pemetrexed
Drug: Dexamethasone

First Posted Date: 2007-07-27

Last Posted Date: 2011-09-23

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 36

Registration Number: NCT00507858

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Home Terms & Conditions Privacy Policy